Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 USD | -3.26% | +23.32% | +118.08% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 11.7M | Sales 2025 * | 5.92M | Capitalization | 722M |
---|---|---|---|---|---|
Net income 2024 * | -90M | Net income 2025 * | -102M | EV / Sales 2024 * | 56.3 x |
Net cash position 2024 * | 62.72M | Net cash position 2025 * | 147M | EV / Sales 2025 * | 97.1 x |
P/E ratio 2024 * |
-9.17
x | P/E ratio 2025 * |
-7.75
x | Employees | 52 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.45% |
Latest transcript on Taysha Gene Therapies, Inc.
1 day | -3.26% | ||
1 week | +23.32% | ||
Current month | +12.54% | ||
1 month | +47.33% | ||
3 months | +42.44% | ||
6 months | +127.06% | ||
Current year | +118.08% |
Managers | Title | Age | Since |
---|---|---|---|
Sean Nolan
CEO | Chief Executive Officer | 56 | 20-02-29 |
Kamran Alam
DFI | Director of Finance/CFO | 46 | 20-07-31 |
President | 58 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philip Donenberg
BRD | Director/Board Member | 63 | 20-08-30 |
Sean Nolan
CEO | Chief Executive Officer | 56 | 20-02-29 |
Sean Stalfort
BRD | Director/Board Member | 53 | 23-06-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 3.86 | -3.26% | 1,745,547 |
24-06-05 | 3.99 | +8.42% | 1,866,267 |
24-06-04 | 3.68 | +1.66% | 2,240,464 |
24-06-03 | 3.62 | +5.54% | 8,015,700 |
24-05-31 | 3.43 | +9.58% | 2,483,172 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.08% | 722M | |
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- TSHA Stock